Urva Dholu - Academia.edu (original) (raw)
Uploads
Papers by Urva Dholu
Cureus, Mar 1, 2023
One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the imple... more One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the implementation of stents into the vessel. This area of research is constantly evolving, ranging from baremetal stents through drug-eluting stents and, more recently, approaching bioresorbable stents and polymerfree stents. This article reviews the evolution of all these devices and emphasizes how they might be further evolved to provide an optimal coronary stent and overcome unsolved challenges in stent development. We thoroughly evaluated a number of published studies in order to advance coronary stent technologies. Additionally, we looked for various literature that highlighted the inadequacies of the coronary stents that are currently available and how they might be modified to create the optimum coronary stent. Coronary stents have significantly improved clinical outcomes in interventional cardiology, but there are still a number of drawbacks, including an persisted risk of thrombosis due to endothelial injury and in-stent restenosis. Gene eluting stents (GES) and customized coronary stents with self-reporting stent sensors are appealing alternatives to existing stent approaches. Considering the adequacy of these gene eluting stents (GES), customized coronary stents produced by novel 4D printing technologies and integrated self-reporting stent sensors should be assumed for anticipating future advancements to optimal coronary stent devices; however, more interventional evidence is required to determine the future prospects of these stent innovations.
Cureus
One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the imple... more One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the implementation of stents into the vessel. This area of research is constantly evolving, ranging from baremetal stents through drug-eluting stents and, more recently, approaching bioresorbable stents and polymerfree stents. This article reviews the evolution of all these devices and emphasizes how they might be further evolved to provide an optimal coronary stent and overcome unsolved challenges in stent development. We thoroughly evaluated a number of published studies in order to advance coronary stent technologies. Additionally, we looked for various literature that highlighted the inadequacies of the coronary stents that are currently available and how they might be modified to create the optimum coronary stent. Coronary stents have significantly improved clinical outcomes in interventional cardiology, but there are still a number of drawbacks, including an persisted risk of thrombosis due to endothelial injury and in-stent restenosis. Gene eluting stents (GES) and customized coronary stents with self-reporting stent sensors are appealing alternatives to existing stent approaches. Considering the adequacy of these gene eluting stents (GES), customized coronary stents produced by novel 4D printing technologies and integrated self-reporting stent sensors should be assumed for anticipating future advancements to optimal coronary stent devices; however, more interventional evidence is required to determine the future prospects of these stent innovations.
International Journal of Advanced Community Medicine
Background: The present study was conducted for assessing patients with ischemic stroke and impac... more Background: The present study was conducted for assessing patients with ischemic stroke and impact of thyroid profile. Materials and Methods: A total of 50 subjects with presence of acute ischemic stroke were enrolled in the present study. Complete demographic and clinical details of all the subjects was obtained. A thorough clinical examination of all the subjects was carried out. All the subjects were broadly divided into two study groups as follows: Group 1:25 subjects with normal consciousness and preserved effective verbal communication, and Group 2:25 subjects with poor verbal communication. Blood samples were obtained from all the patients and serum thyroid profile was evaluated. Results: Among group 1 and group 2 subjects, majority of them had serum TSG and fT4 values within normal reference range. However, fT3 values were significantly altered among subjects of group 2. Conclusion: Although most of the patients with acute ischemic stroke have normal thyroid function, a small proportion of patients requires further evaluation.
Cureus, Mar 1, 2023
One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the imple... more One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the implementation of stents into the vessel. This area of research is constantly evolving, ranging from baremetal stents through drug-eluting stents and, more recently, approaching bioresorbable stents and polymerfree stents. This article reviews the evolution of all these devices and emphasizes how they might be further evolved to provide an optimal coronary stent and overcome unsolved challenges in stent development. We thoroughly evaluated a number of published studies in order to advance coronary stent technologies. Additionally, we looked for various literature that highlighted the inadequacies of the coronary stents that are currently available and how they might be modified to create the optimum coronary stent. Coronary stents have significantly improved clinical outcomes in interventional cardiology, but there are still a number of drawbacks, including an persisted risk of thrombosis due to endothelial injury and in-stent restenosis. Gene eluting stents (GES) and customized coronary stents with self-reporting stent sensors are appealing alternatives to existing stent approaches. Considering the adequacy of these gene eluting stents (GES), customized coronary stents produced by novel 4D printing technologies and integrated self-reporting stent sensors should be assumed for anticipating future advancements to optimal coronary stent devices; however, more interventional evidence is required to determine the future prospects of these stent innovations.
Cureus
One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the imple... more One of the most widely accepted forms of treatment for coronary artery disease (CAD) is the implementation of stents into the vessel. This area of research is constantly evolving, ranging from baremetal stents through drug-eluting stents and, more recently, approaching bioresorbable stents and polymerfree stents. This article reviews the evolution of all these devices and emphasizes how they might be further evolved to provide an optimal coronary stent and overcome unsolved challenges in stent development. We thoroughly evaluated a number of published studies in order to advance coronary stent technologies. Additionally, we looked for various literature that highlighted the inadequacies of the coronary stents that are currently available and how they might be modified to create the optimum coronary stent. Coronary stents have significantly improved clinical outcomes in interventional cardiology, but there are still a number of drawbacks, including an persisted risk of thrombosis due to endothelial injury and in-stent restenosis. Gene eluting stents (GES) and customized coronary stents with self-reporting stent sensors are appealing alternatives to existing stent approaches. Considering the adequacy of these gene eluting stents (GES), customized coronary stents produced by novel 4D printing technologies and integrated self-reporting stent sensors should be assumed for anticipating future advancements to optimal coronary stent devices; however, more interventional evidence is required to determine the future prospects of these stent innovations.
International Journal of Advanced Community Medicine
Background: The present study was conducted for assessing patients with ischemic stroke and impac... more Background: The present study was conducted for assessing patients with ischemic stroke and impact of thyroid profile. Materials and Methods: A total of 50 subjects with presence of acute ischemic stroke were enrolled in the present study. Complete demographic and clinical details of all the subjects was obtained. A thorough clinical examination of all the subjects was carried out. All the subjects were broadly divided into two study groups as follows: Group 1:25 subjects with normal consciousness and preserved effective verbal communication, and Group 2:25 subjects with poor verbal communication. Blood samples were obtained from all the patients and serum thyroid profile was evaluated. Results: Among group 1 and group 2 subjects, majority of them had serum TSG and fT4 values within normal reference range. However, fT3 values were significantly altered among subjects of group 2. Conclusion: Although most of the patients with acute ischemic stroke have normal thyroid function, a small proportion of patients requires further evaluation.